SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019901
Filing Date
2024-07-22
Accepted
2024-07-22 20:01:03
Documents
2
Period of Report
2024-07-19

Document Format Files

Seq Description Document Type Size
1 form3-07232024_120759.html 3  
1 form3-07232024_120759.xml 3 1689
2 ex24-07232024_120759.htm EX-24 4806
  Complete submission text file 0001415889-24-019901.txt   7939
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40475 | Film No.: 241132672

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)